Serv­ing as a 'gate­way,' Cam­bridge ven­ture in­vestor clos­es $300M sec­ond fund

For a world-renowned and sto­ried aca­d­e­m­ic in­sti­tu­tion with mul­ti­ple No­bel lau­re­ates and top-notch bio­med­ical re­searchers to boast, the Uni­ver­si­ty of Cam­bridge is be­hind a dis­pro­por­tion­ate­ly small num­ber of promi­nent — not to men­tion world-lead­ing — life sci­ences com­pa­nies.

Cam­bridge In­no­va­tion Cap­i­tal set out al­most nine years ago to change that. The goal was sim­ple: It would take the cut­ting-edge sci­ence com­ing out of the Cam­bridge ecosys­tem, which in­cludes not just the uni­ver­si­ty but al­so a hos­pi­tal sys­tem and sev­er­al af­fil­i­at­ed re­search in­sti­tu­tions, and pro­vide spin­outs with the mon­ey, tal­ent and net­work they need to suc­ceed. Specif­i­cal­ly, it aimed to be the pre­ferred Se­ries A in­vestor for any life sci­ence com­pa­nies emerg­ing out of the city (it al­so in­vests in deep tech com­pa­nies).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER